Eva Situ is an experienced in vivo pharmacologist currently serving as an R&D Program Manager at Gate Bioscience since 2025. Previously, they held positions as a Scientist II and Scientist I at Maze Therapeutics from 2022 to 2023, and as a Nonclinical Study Manager at Gate Bioscience since 2023. Eva's earlier experience includes various roles at Theravance Biopharma US, Inc. and Samumed, where they contributed significantly to research and development efforts. They earned a Bachelor of Science in Bioengineering and Biomedical Engineering from the University of California, San Diego, between 2005 and 2010.
This person is not in the org chart
This person is not in any teams
This person is not in any offices